California Law (Last Updated: March 4, 2014) |
Health and Safety Code - HSC |
Division 106. PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT) |
Part 5. HEREDITARY DISEASES/CONGENITAL DEFECTS |
Chapter 3. California Stem Cell Research and Cures Bond Act |
ARTICLE 1. California Stem Cell Research and Cures Act |
Section 125290.40.
-
ICOC Functions
The ICOC shall perform the following functions:
(a) Oversee the operations of the institute.
(b) Develop annual and long-term strategic research and financial plans for the institute.
(c) Make final decisions on research standards and grant awards in California.
(d) Ensure the completion of an annual financial audit of the institute's operations.
(e) Issue public reports on the activities of the institute.
(f) Establish policies regarding intellectual property rights arising from research funded by the institute.
(g) Establish rules and guidelines for the operation of the ICOC and its working groups.
(h) Perform all other acts necessary or appropriate in the exercise of its power, authority, and jurisdiction over the institute.
(i) Select members of the working groups.
(j) Adopt, amend, and rescind rules and regulations to carry out the purposes and provisions of this chapter, and to govern the procedures of the ICOC. Except as provided in subdivision (k), these rules and regulations shall be adopted in accordance with the Administrative Procedure Act (Government Code, Title 2, Division 3, Part 1, Chapter 4.5, Sections 11371 et seq.).
(k) Notwithstanding the Administrative Procedure Act (APA), and in order to facilitate the immediate commencement of research covered by this chapter, the ICOC may adopt interim regulations without compliance with the procedures set forth in the APA. The interim regulations shall remain in effect for 270 days unless earlier superseded by regulations adopted pursuant to the APA.
(l) Request the issuance of bonds from the California Stem Cell Research and Cures Finance Committee and loans from the Pooled Money Investment Board.
(m) May annually modify its funding and finance programs to optimize the institute's ability to achieve the objective that its activities be revenue-positive for the State of California during its first five years of operation without jeopardizing the progress of its core medical and scientific research program.
(n) Notwithstanding Section 11005 of the Government Code, accept additional revenue and real and personal property, including, but not limited to, gifts, royalties, interest, and appropriations that may be used to supplement annual research grant funding and the operations of the institute.
(o) Under the guidance of the ICOC, the institute shall create a succession plan addressing changes in leadership of both the institute and the ICOC designed to minimize disruption and adverse impacts to the activities of the institute. A copy of the succession plan shall be transmitted to the Governor, Controller, and the Legislature within 30 days of its completion. The succession plan should include, but is not limited to:
(1) An assessment of leadership needs before beginning a search.
(2) An outline of succession procedures.
(3) Strategies to ensure successful knowledge transfer.